至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR

Science. 2020-02; 
Laura M. Wingler, Meredith A. Skiba, Conor McMahon, Dean P. Staus, Alissa L. W. Kleinhenz, Carl-Mikael Suomivuori, Naomi R. Latorraca, Ron O. Dror, Robert J. Lefkowitz*, Andrew C. Kruse*
Products/Services Used Details Operation
Peptide Synthesis The receptor was incubated with 250 µM crystallization ligand (AngII, TRV023, TRV026; Genscript) for 30 minutes at room temperature. Get A Quote

摘要

Biased agonists of G protein–coupled receptors (GPCRs) preferentially activate a subset of downstream signaling pathways. In this work, we present crystal structures of angiotensin II type 1 receptor (AT1R) (2.7 to 2.9 angstroms) bound to three ligands with divergent bias profiles: the balanced endogenous agonist angiotensin II (AngII) and two strongly β-arrestin–biased analogs. Compared with other ligands, AngII promotes more-substantial rearrangements not only at the bottom of the ligand-binding pocket but also in a key polar network in the receptor core, which forms a sodium-binding site in most GPCRs. Divergences from the family consensus in this region, which appears to act as a biased signaling switc... More

关键词